Using Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSIs) in Obese Patients: A Real-Life, Single-Center Observational Study
<b>Background/Objectives</b>: Obesity is an established risk factor for several infective conditions, including Acute Bacterial Skin and Skin Structure Infections (ABSSSIs), with a rising trend in their incidence expected in this population. Although numerous antibiotics are available fo...
Saved in:
Main Authors: | Alessandra Oliva, Flavia Petrucci, Cristiana Leanza, Marco Rivano Capparuccia, Michela Comi, Claudio Mastroianni |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-01-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6382/14/1/75 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The effects of the gut bacterial product, gassericin A, on obesity in mice
by: Valeh Mahdavi, et al.
Published: (2025-01-01) -
Primary and Secondary Prevention of Obesity
by: Aleksandra Kiełczewska, et al.
Published: (2025-01-01) -
OBESITY AS A SPECIFIC OBSTACLE SUSTAINABLE SOCIAL AND ECONOMIC DEVELOPMENT
by: S. Kuzin, et al.
Published: (2016-07-01) -
Evaluating Digital Rehabilitation Outcomes in Chronic Musculoskeletal Conditions Across Non-Obesity, Obesity, and Severe Obesity [Letter]
by: Zeng X
Published: (2025-01-01) -
Definition, criteria, and core concepts of guidelines for the management of obesity disease in Japan
by: Wataru Ogawa, et al.
Published: (2024-03-01)